and attended conferences sponsored by TrigoCare International, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, GSK, Novartis, Novo Nordisk, Pfizer and Sanofi Aventis
An artificial pancreas is a system that uses a computer to deliver insulin based on real-time blood sugar readings
Most patients notice meaningful appetite reduction within the first few weeks, with progressive weight loss continuing over the course of the program
Endocrinology (2010) 151:147386
AI can also combine a patient's GLP-1 treatment duration, rate of weight loss, bone density score, and vitamin D levels to generate a personalized bone fracture risk score, tailoring the recommendation for calcium/vitamin D supplementation or the timing of a bone density check